UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$488M |
| 2 |
NXP Semiconductors
NXPI
|
+$484M |
| 3 |
JPMorgan Chase
JPM
|
+$429M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$426M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$755M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
PepsiCo
PEP
|
+$387M |
| 5 |
Meta Platforms (Facebook)
META
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.14% |
| 2 | Financials | 7.54% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.09% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Acadia Healthcare
ACHC
$2.94B
| $3.01M | ﹤0.01% |
76,738
+36,045
| +89% | +$1.32M |
|
2752
Green Dot
GDOT
$745M
| $3M | ﹤0.01% |
46,719
+17,333
| +59% | +$1.09M |
|
2753
CALL
Estee Lauder
EL
$32B
| $2.99M | ﹤0.01% |
20,000
+7,317
| +58% | +$1.01M |
|
2754
State Street SPDR S&P Health Care Services ETF
XHS
$208M
| $2.99M | ﹤0.01% |
47,507
-625
| -1% | -$40.3K |
|
2755
B2Gold
BTG
$6.64B
| $2.99M | ﹤0.01% |
1,094,987
-109,738
| -9% | -$323K |
|
|
SYNT
2756
DELISTED
Syntel Inc
SYNT
| $2.98M | ﹤0.01% |
116,676
+72,425
| +164% | +$1.79M |
|
|
IBMG
2757
DELISTED
iShares iBonds Sep 2018 Term Muni Bond ETF
IBMG
| $2.98M | ﹤0.01% |
117,214
-241,967
| -67% | -$6.14M |
|
2758
VanEck Long Muni ETF
MLN
$683M
| $2.97M | ﹤0.01% |
149,278
-6,508
| -4% | -$129K |
|
2759
Installed Building Products
IBP
$6.49B
| $2.96M | ﹤0.01% |
49,334
-19,085
| -28% | -$1.27M |
|
2760
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$310M
| $2.96M | ﹤0.01% |
94,908
-84,868
| -47% | -$2.73M |
|
2761
Teck Resources
TECK
$32.6B
| $2.95M | ﹤0.01% |
114,558
-21,782
| -16% | -$614K |
|
2762
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $2.94M | ﹤0.01% |
294,155
-833,876
| -74% | -$8.23M |
|
|
ATH
2763
CALL
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $2.94M | ﹤0.01% |
+61,600
| New | +$3.07M |
|
2764
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$174M
| $2.94M | ﹤0.01% |
73,319
+19,449
| +36% | +$811K |
|
2765
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
| $2.94M | ﹤0.01% |
57,311
+47,634
| +492% | +$2.45M |
|
|
AXON
2766
Axon Enterprise
AXON
$46.4B
| $2.94M | ﹤0.01% |
74,707
-14,022
| -16% | -$437K |
|
2767
iShares MSCI France ETF
EWQ
$345M
| $2.94M | ﹤0.01% |
93,490
-8,503
| -8% | -$272K |
|
2768
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$531M
| $2.94M | ﹤0.01% |
30,346
+13,923
| +85% | +$1.36M |
|
2769
NCR Voyix
VYX
$1.14B
| $2.93M | ﹤0.01% |
151,336
+30,806
| +26% | +$649K |
|
|
ESL
2770
DELISTED
Esterline Technologies
ESL
| $2.92M | ﹤0.01% |
39,985
+27,219
| +213% | +$2.03M |
|
2771
Essent Group
ESNT
$6.33B
| $2.92M | ﹤0.01% |
68,578
-8,674
| -11% | -$393K |
|
2772
CALL
The Mosaic Company
MOS
$7.33B
| $2.91M | ﹤0.01% |
120,000
+11,400
| +10% | +$300K |
|
|
KNOW
2773
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
| $2.91M | ﹤0.01% |
71,213
-18,886
| -21% | -$788K |
|
|
LJPC
2774
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.91M | ﹤0.01% |
97,622
+82,109
| +529% | +$2.65M |
|
|
ALDR
2775
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.91M | ﹤0.01% |
228,837
+212,303
| +1,284% | +$3.07M |
|
Similar funds
UBS Group's Q1 2018 Portfolio in Review
As of Q1 2018, UBS Group held 8,641 positions worth $232B, down 4.8% from $243B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $8.61B in Q1 2018, closing 751 positions and reducing 3,579 holdings. Its most notable exit was CalAtlantic Group, Inc., an estimated $60.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Nutrien worth $56.3M.
- UBS Group's largest Q1 2018 buy was Nutrien: 1,191,668 shares worth $56.3M.
- UBS Group added most to Comcast in Q1 2018, an estimated $488M increase.
- UBS Group's biggest Q1 2018 reduction was UBS Group, cutting an estimated $755M.
- UBS Group fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $60.8M.
- UBS Group's ten largest holdings make up 15% of its $232B portfolio in Q1 2018.
- UBS Group opened 725 new positions and closed 751 in Q1 2018.
- UBS Group's portfolio value fell 4.8% quarter-over-quarter to $232B.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.